Skip to content
Saturday, November 14, 2026
PrimeReelsHouse UK

Individuals Stopping Slimming Medications Gain Back Weight Far More Rapidly Than Those on Conventional Diets

Image of medical syringe and scale
Obesity treatment involves ongoing approaches.

A recent study suggests that patients who stop using new slimming jabs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end conventional diet and exercise programs.

Findings released in a prominent medical journal points out that while obese individuals can lose substantial amounts of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.

"People using such medications need to be aware of the potential of fast weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery suggests a return to original mass in about a year and a half.

Comparing Approaches

The study, which reviewed dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with conventional dieting.

The team note that people who shed pounds through dieting typically experience a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Doctors suggest the mode of action of the jabs is key to understanding the amplified regain.

These medications mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in hunger is uncontrolled, making excessive eating a significant risk."

A Lifelong Condition?

Health authorities recommend the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

Many experts say that, considering the likelihood of weight regain, the treatment is often long-term.

This view is supported by pharmaceutical companies, who say that the findings "underscore the persistent nature of excess weight," akin to managing conditions like hypertension.

User Experiences

People who have come off the medication explain a intense return of hunger.

"It felt as if a switch that goes on and you're instantly extremely hungry," described a patient.

This difficulty is compounded if individuals have not adopted lasting lifestyle or habit changes during therapy.

Growing Use

Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.

  • Adoption is greater among females than males.
  • The middle-aged demographic shows the highest usage rates.
  • Many obtain the drugs through private healthcare rather than public health services.

In conclusion, clinicians stress that while these medications are effective tools for shedding pounds, they are not a permanent cure and long-term success hinges on ongoing behavioural support.

RB
Written by

Rachel Butler

Eleanor Vance is a film critic and entertainment journalist with over a decade of experience covering cinema and streaming content.

PrimeReelsHouse UK

Type to search articles.